SGRY
Surgery Partners, Inc.
-0.21 (-1.51%)13.72USD2.3M成交股數1.8B市值–本益比(近四季)0.5股價營收比+2.8%營收年增(近四季)2026-11-09下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 849M+3% | 811M+4% | 885M+15% | 822M+8% | 826M+15% | 776M+6% | 770M+14% | 762M+14% | 717M | 735M | 674M | 668M |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | – | – | – | – | – | – | – | – | – | – | – | – |
| 銷售管理費用 | 36.3M | 39.3M | 23.7M | 22.4M | 36.1M | 36.0M | 29.2M | 40.3M | 33.2M | 20.9M | 36.8M | 31.2M |
| 營業利益 | 102M-9% | 65.8M+6% | 110M+81% | 106M+25% | 112M+47% | 61.9M-39% | 60.9M-26% | 84.8M-13% | 76.0M | 101M | 82.6M | 97.6M |
| 營業利益率 | 12.0% | 8.1% | 12.5% | 12.9% | 13.5% | 8.0% | 7.9% | 11.1% | 10.6% | 13.8% | 12.3% | 14.6% |
| 稅後淨利 | −15.0M+500% | −35.9M-5% | −15.0M-53% | −22.7M+46% | −2.5M-80% | −37.7M+3670% | −31.7M+547% | −15.5M-182% | −12.4M | −1.0M | −4.9M | 18.9M |
| 淨利率 | -1.8% | -4.4% | -1.7% | -2.8% | -0.3% | -4.9% | -4.1% | -2.0% | -1.7% | -0.1% | -0.7% | 2.8% |
| 稀釋 EPS | -0.12+500% | -0.28-7% | -0.11-56% | -0.18+50% | -0.02-80% | -0.30 | -0.25+525% | -0.12-180% | -0.10 | 0.00 | -0.04 | 0.15 |
| 稀釋股數 | 129M | 128M | 127M | 127M | 127M | 127M | 126M | 126M | 126M | 126M | 126M | 127M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 217M | 182M | 240M | 203M | 250M | 229M | 222M | 214M | 185M | 196M | 236M | 177M |
| 應收帳款 | 617M | 603M | 602M | 579M | 563M | 571M | 543M | 523M | 494M | 496M | 463M | 450M |
| 存貨 | 98.8M | 101M | 96.6M | 92.3M | 87.3M | 88.1M | 82.0M | 80.9M | 77.0M | 75.2M | 69.4M | 70.3M |
| 總資產 | 8.0B | 8.0B | 8.1B | 7.9B | 8.0B | 7.9B | 7.5B | 7.5B | 7.0B | 6.9B | 6.8B | 6.6B |
| 有息負債 | 3.6B | 3.6B | 3.7B | 3.5B | 3.5B | 3.4B | 3.1B | 3.0B | 2.8B | 2.8B | 2.6B | 2.5B |
| 總負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 股東權益 | 1.7B | 1.7B | 1.7B | 1.7B | 1.7B | 1.7B | 1.9B | 2.0B | 2.0B | 2.0B | 2.0B | 2.0B |
| 負債比 | – | – | – | – | – | – | – | – | – | – | – | – |
| 淨現金(現金 − 有息負債) | −3.4B | −3.4B | −3.5B | −3.3B | −3.2B | −3.2B | −2.9B | −2.8B | −2.6B | −2.6B | −2.4B | −2.3B |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | 11.7M+95% | – | – | – | 6.0M | – | – | 40.7M | – | – | – |
| 資本支出 | – | 16.0M | – | – | – | 22.7M | – | – | 21.0M | – | – | – |
| 自由現金流 | – | −4.3M-74% | – | – | – | −16.7M | – | – | 19.7M | – | – | – |
| 折舊攤銷 | 39.3M | 38.5M | 59.9M | 39.5M | 40.3M | 36.3M | 50.2M | 34.8M | 33.7M | 31.1M | 28.9M | 24.4M |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | -0.5% | – | – | – | -2.2% | – | – | 2.7% | – | – | – |
營收拆解 2025 年度 10-K 的分部揭露 · 年增對前一年度
業務分部2025 年度 · 3.3B
| Surgical Facilities | 3.3B | 100.0% | +6.2% |
|---|
產品／服務2025 年度 · 6.5B
| Healthcare Organization Patient Service | 3.2B | 49.4% | +5.6% |
|---|---|---|---|
| Private Insurance | 1.7B | 25.8% | +3.2% |
| Government Revenue | 1.4B | 21.1% | +9.8% |
| Self Pay Revenue | 87.6M | 1.3% | +6.4% |
| Other Services | 82.4M | 1.3% | +37.6% |
| Other Patient Service Revenue Sources | 71.2M | 1.1% | -12.2% |
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 3.3B | +6.2% | −77.9M | -2.4% | -0.61 | 196M |
| FY2024 | 3.1B | +13.5% | −168M | -5.4% | -1.33 | 210M |
| FY2023 | 2.7B | +8.0% | −11.9M | -0.4% | -0.09 | 205M |
| FY2022 | 2.5B | +14.1% | −54.6M | -2.2% | -0.59 | 78.2M |
| FY2021 | 2.2B | +19.6% | −70.9M | -3.2% | -1.12 | 29.5M |
| FY2020 | 1.9B | +1.6% | −116M | -6.2% | -3.19 | 204M |
| FY2019 | 1.8B | +3.4% | −74.8M | -4.1% | -2.29 | 55.9M |
| FY2018 | 1.8B | – | −206M | -11.6% | -4.96 | 105M |